 | Ocular Therapeutix, Inc. | |||
| NGM : OCUL || Location: United States | ||||
$5.02-0.84 (-14.33%) |
6.39 M | 4.98 - 5.9 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 11.808 M |
| March 15, 2024 | 9.164 M |
| Feb. 29, 2024 | 4.739 M |
| Feb. 15, 2024 | 3.966 M |
| Jan. 31, 2024 | 3.960 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.31 | -0.35 | -12.87% |
| 09/30/2023 | -0.29 | -0.17 | 41.98% |
| 06/30/2023 | -0.31 | -0.26 | 15.58% |
| 03/31/2023 | -0.27 | -0.39 | -45.09% |
| 12/31/2022 | -0.26 | -0.24 | 7.12% |
OCUL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 148.627M | Shares Float | 128.468M |
| Short Float | 11.808M | Market Cap | 870.95M |
| Institution ownership | 50.09% | Insider ownership | 3.681% |
| Earnings Date | 05/10/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.99 | Forward EPS | -0.88 |